Dialysis Access Treatment Devices | Market Insights | Japan | 2024
The Japanese dialysis access treatment device market will be driven by significant rise in ESRD population and will grow modestly through 2032. New product launches such as DCB, DES, and percutaneous AVFs along with the favorable clinical trials results associated with these devices are expected to positively impact the market. The impact of the COVID-19 pandemic in the short term, as well as ASP declines caused by MHLW biennial reimbursement cuts over the forecast period, will limit market revenues.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for dialysis access treatment products in Japan from 2019 through 2032.
